Meet with us at AES Annual Meeting!
Bringing an innovative therapy forward requires more than a compelling asset. Regulatory expectations, clinical strategy, operational feasibility, and business priorities must be aligned to create a clear and executable development path.
At BIO-Europe 2026, connect with Premier Research’s regulatory affairs and business development leaders to discuss your program goals and the expertise needed to move them forward. From early development and global regulatory planning to study design and full-service execution, our integrated teams help biotech and biopharma companies navigate complexity, reduce risk, and prepare for critical milestones.
Connect with our team to discuss:
- Global regulatory strategy across key stages of development
- Health authority interactions, submission planning, and regulatory operations
- Clinical development strategy and fit-for-purpose delivery models
- Integrated support that connects regulatory, scientific, operational, and business priorities
On-Site
- Federica Martini, Director of Regulatory Affairs
- Veronica Yildirim, Director, Business Development
- Alan Syu, Director, Business Development
Fill out the form above to schedule a meeting with our on-site team.
Meet with us in Cologne to explore a practical path from promising science to clinical progress.
